Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies Review

sustainable development goals

publication date

  • September 1, 2020

webpage

published in

keywords

  • Cytoxan
  • EGFR
  • K-RAS
  • SIAH signaling pathway
  • and Taxotere)
  • chemo-resistance
  • clinical diagnostics
  • concurrent ACT regimen (Adriamycin
  • improved patient survival
  • neoadjuvant chemotherapy (NACT)
  • pathologic incomplete responders (pIR)
  • prognostics
  • residual cancer burden (RCB)
  • sequential ACT regimen (AC-T)
  • triple-negative breast cancer (TNBC)
  • tumor recurrence
  • tumor-driving signaling pathways in TNBC

volume

  • 12

issue

  • 9